Is silent cerebrovascular disease an important cause of late-life cognitive decline?

Journal of the American Geriatrics Society

Volumn 44, Issue 3, 1996, Pages 328-330

  White, Lon ^a  

^a Honolulu Asia Aging Study   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; AGED; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; GERIATRIC ASSESSMENT; HUMAN; MENTAL HEALTH; NOTE;

AGE FACTORS; AGED; CEREBROVASCULAR DISORDERS; COGNITION DISORDERS; GERIATRIC ASSESSMENT; HUMANS; MENTAL STATUS SCHEDULE;

EID: 0030097239     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1996.tb00925.x     Document Type: Editorial

References (36)

1. Ferrucci L, Guralnik JM, Salive ME, et al., Cognitive impairment and risk of stroke in the older population. J Am Geriatr Soc 1996; 44: 237-241.
2. Graves AB, Larson EB, White LR, et al., Opportunities and challenges in international collaborative epidemiologic research of dementia and its subtypes: Studies between Japan and the U.S. Int Psychogeriatr 1994; 6: 209-223.
3. Brainin JM, McShane LM, Dachenhausen A, Seiser A,. Silent brain infarcts and transient ischemic attacks. A three-year study of first-ever ischemic stroke patients: The Klosterneuburg Stroke Data Bank. Stroke 1995; 26: 1348-1352.
4. Boon A, Lodder J, Heuts-van Rank L, Kellels F,. Silent brain infarcts in 755 consecutive patients with a first-ever supratentorial ischemic stroke. Relationship with index stroke subtype, vascular risk factors, and mortality. Stroke 1994: 25: 2384-2390.
5. Brott T, Tomsick T, Feinberg W, et al., Baseline silent cerebral infarction in the Asymptomatic Carotid Atherosclerosis Study. Stroke 25; 25: 1122-1129.
6. Laloux P, Ossermann M, Jamart J,. Stroke subtypes and risk factors associated with silent infarctions in patients with first-ever ischemic stroke or transient ischemic attack. Acta Neurol Belg 1994; 94: 17-23.
7. Jorgensen HS, Nakayama H, Raaschou HO, et al., Silent infarction in acute stroke patients. Prevalence, localization, risk factors, and clinical significance: The Copenhagen Stroke Study. Stroke 1994; 25: 97-104.
8. Fujikawa T, Yamawaki S, Touhouda Y,. Incidence of silent cerebral infarction in patients with major depression. Stroke 1993; 24: 1631-1634.
9. Mounier-Vehier F, Leys D, Rondipierre P, et al., Silent infarcts in patients with ischemic stroke are related to age and size of the left atrium. Stroke 1993; 24: 1347-1351.
10. Ricci S, Celani MG, La Rosa F, et al., Silent brain infarctions in patients with first-ever stroke. A community-based study in Umbria, Italy. Stroke 1993; 24: 647-651.
11. Hougaku H, Matsumoto M, Handa N, et al., Asymptomatic carotid lesions and silent cerebral infarction. Stroke 1994; 25: 566-570.
12. Schmidt R, Fazekas F, Kleinert G, et al., Magnetic resonance imaging signal hyperintensities in the deep and subcortical white matter. A comparative study between stroke patients and normal volunteers. Arch Neurol 1992; 49: 825-827.
13. Herderschee D, Hijdra A, Algra A, et al., Silent infarction on a second CT scan in 91 patients without manifest stroke in the Dutch TIA trial. Clin Neurol Neurosurg 1994; 96: 219-221.
14. Arboix A, Marti-Vilalta JL, Garcia JH,. Clinical study of 227 patients with lacunar infarcts. Stroke 1990; 21: 842-847.
15. Bryan RN, Manolio TA, Schertz LD, et al., A method for using MR to evaluate the effects of cardiovascular disease on the brain: The cardiovascular health study. AJNR Am J Neuroradiol 1994; 15: 1625-1633.
16. Shinkawa A, Ueda K, Kiyohara Y, et al., Silent cerebral infarction in a community-based autopsy series in Japan: The Hisayama study. Stroke 1995; 26: 380-385.
17. Thorpe J, Widman LP, Wallin A, et al., Comorbidity of other chronic age-dependent diseases in dementia. Aging 1994; 6: 159-166.
18. Ross GW, Hardman J, Petrovitch H, et al., Cerebrovascular disease in an unselected autopsy series of elderly Japanese-American men. Neurology 1995; 45 (suppl 4): A460.
19. Dozono K, Ishii N, Nishihara Y, Horie A,. An autopsy study of the incidence of lacunes in relation to age, hypertension, and arteriosclerosis. Stroke 1991; 22: 993-996.
20. George AE, de Leon MJ, Gentes CI, et al., Leukoencephalopathy in normal and pathologic aging I. CT of brain lucencies. Am J Neuroradiol 1986; 7: 561-566.
21. Lechner H, Schmidt R, Bertha G, et al., Nuclear magnetic resonance image white matter lesions and risk factors for stroke in normal individuals. Stroke 1988; 19: 263-265.
22. Tanaka H, Sueyoshi K, Nishino M, et al., Silent brain infarction and coronary artery disease in Japanese patients. Arch Neurol 1993; 50: 706-709.
23. Kase CS, Wolf PA, Chodosh EH, et al., Prevalence of silent stroke in patients presenting with initial stroke: The Framingham Study. Stroke 1989; 20: 850-852.
24. Tuszynski MH, Petito CK, Levy DE,. Risk factors and clinical manifestations of pathologically verified lacunar infarctions. Stroke 1989; 20: 990-999.
25. Ikeda T, Gomi T, Kobayashi S, Tsuchiya H,. Role of hypertension in asymptomatic cerebral lacunae in the elderly. Hypertension 1994; 23 (suppl 1):I 259-262.
26. Nakamura K, Oita J, Yamaguchi T,. Nocturnal blood pressure dip in stroke survivors. A pilot study. Stroke 1995; 26: 1373-1378.
27. Shimada K, Kawamoto A, Matsubayashi K, et al., Diurnal blood pressure variations and silent cerebrovascular damage in elderly patients with hypertension. J Hypertens 1992; 10: 875-878.
28. Elias MF, Wolf PA, D'Agostino RB, et al., Untreated blood pressure level is inversely related to cognitive functioning: The Framingham Study. Am J Epidemiol 1993; 138: 353-364.
29. Launer LJ, Masaki K, Petrovitch H, et al., The association between midlife blood pressure levels and late life cognitive function: The Honolulu-Asia Aging Study. JAMA 1995; 274: 1846-1851.
30. Scheinberg P,. Dementia due to vascular disease-A multifactorial disorder. Stroke 1988; 19: 1291-1299.
31. Meyer JS, Judd BW, Tawaklna T, et al., Improved cognition after control of risk factors for multi-infarct dementia. JAMA 1986; 256: 2203-2209.
32. Franceschi M, Alberoni M, Bressi S, et al., Correlations between cognitive impairment, middle cerebral artery flow velocity and cortical glucose metabolism in the early phase of Alzheimer's disease. Dementia 1995; 6: 32-38.
33. Rapoport SI, Grady CL,. Parametric in vivo brain imaging during activation to examine pathological mechanisms of functional failure in Alzheimer disease. Int J Neurosci 1993; 70: 39-56.
34. Kosunen O, Talasniemi S, Lehtovirta M, et al., Relation of coronary atherosclerosis and apolipoprotein E genotypes in Alzheimer patients. Stroke 1995; 26: 743-748.
35. Prince M, Cullen M, Mann A,. Risk factors for Alzheimer's disease and dementia: A case-control study based on the MRC elderly hypertension trial. Neurology 1994; 44: 97-104.
36. Hofman A, Bots ML, Breteler MMB, et al., Atherosclerosis and dementia: The Rotterdam study. Neurology 1995; 45 (suppl 4): A214.